What is Edgewise Therapeutics, Inc. (EWTX)?
Edgewise Therapeutics, Inc. is a biotechnology company focused on the development of therapies targeting diseases involving endothelial dysfunction and vascular inflammation. The company employs proprietary technology platforms to identify and develop small molecule drugs aimed at modulating cellular pathways. Its research efforts concentrate on conditions such as pulmonary arterial hypertension and other vascular-related disorders. Edgewise Therapeutics engages in preclinical and clinical development activities to advance its pipeline candidates. The company operates within the biopharmaceutical sector, emphasizing innovation in therapeutic approaches to address unmet medical needs.
Edgewise Therapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by trading movements, as Cullinan Therapeutics Inc trades at $32.58. It has seen an intraday low of $30.84 and a high of $31.45, with a daily change of +2.4199%.
FAQ: Edgewise Therapeutics, Inc. (EWTX)
What is the current price of EWTX stock?
Edgewise Therapeutics, Inc. is currently priced at $32.58.
Does EWTX pay dividends?
Edgewise Therapeutics, Inc. does not pay dividends.
Does EWTX have a formal corporate presence or regional headquarters in the UAE?
Edgewise Therapeutics, Inc. operates in the UAE through partners and distributors only.
What is EWTX best known for?
The company is most famous for developing therapies targeting protein degradation.
What assets are typically shown together with EWTX?
Commonly shown alongside EWTX: Invesco BulletShares 2030 Corporate Bond ETF, UroGen Pharma Ltd., SanDisk Corp
Latest shares articles



